All Episodes
Glaucoma, Vision & Longevity: Supplements & Science — 251 episodes
Could Glaucoma Surgery Become a 10-Minute Office Procedure? First Human Results From OBi Core
Can High-Dose Vitamin B3 Protect the Optic Nerve? A New Glaucoma Trial Will Test 3 Grams a Day
Four New Glaucoma Developments From the Last Two Weeks — Which One Could Matter Most for Patients?
A New Glaucoma Drug Is Approaching FDA Approval — Can It Lower Eye Pressure Better Than Today's Best Drops?
A New Scan May Detect Glaucoma Progression Years Before It Shows Up on a Visual Field Test
Scientists Found a New Abnormality Inside Human Glaucoma Nerve Cells — Could It Lead to a New Treatment?
A Glaucoma Eye Drop Designed to Protect the Optic Nerve Is Already in Phase II Trials
Helping Eye Cells Take Out Their Trash May Protect the Optic Nerve From Glaucoma
Could One Extra Injection Make Glaucoma Surgery Last Longer? New Evidence Points to Better Trabeculectomy Success
Can Damaged Optic Nerve Cells Be Made Young Again? The First Human Glaucoma Reprogramming Trial Has Begun
A New Glaucoma Gene Therapy Is Entering Human Trials — Could It Protect Vision Without Lowering Eye Pressure?
Gene-Based Interventions for Myocilin-Associated Glaucoma: August 2026 First-in-Human Learnings
Smart Contact Lenses for IOP Monitoring: August 2026 Clinical Utility Results
Dry Eye Disease: August 2026 Phase II/III Results for Novel Mechanisms
Teleophthalmology for Rural and Underserved Populations: August 2026 Outcomes Trial
Smart Contact Lenses for IOP Monitoring: August 2026 Clinical Utility Results
A New Target for Protecting the Optic Nerve? Human Glaucoma Study Strengthens the Case Against Galectin-3
Nicotinamide/B3 gets surprisingly strong human glaucoma evidence
Can Glaucoma Damage Be Reversed? First Human Epigenetic Reprogramming Trial Targets the Optic Nerve
Why Visual Fields Matter: From Silent Loss to Real-World Function
Do More Data Points Reveal Clearer Trends? Power and Noise in VF Progression
Patient Education to Improve VF Performance and Reduce Anxiety
Who Should Get Visual Field Testing? A Population-Based Framework
Real-World Evidence: Outcomes When Testing Frequency Increases
Oxidative Stress Pathways from High Sugar Exposure: Nrf2, Mitochondria, and RGC Survival
Aspartame, Sucralose, Saccharin, and Stevia: Comparative Mechanistic Plausibility in Glaucoma
Does Dietary Sugar Intake Increase Glaucoma Risk? A Systematic Review and Meta-analysis Blueprint
Global Eye Health 2026: Tackling Glaucoma Disparities
Glaucoma and High Myopia: Mid-2026 Clinical Insights
Managing Glaucoma in Pregnancy 2026: Evidence and Consensus
Wound Healing Modulation 2026: Anti-fibrotics in Filtering Surgery
Vision for 2030: What July 2026 Glaucoma Trends Mean for the Next Four Years
Personalizing a supplement plan after trabeculectomy
Vitamin D status and trabeculectomy outcomes
Vitamin D status and trabeculectomy outcomes
Alpha-lipoic acid: Oxidative stress, neuropathy, and glycemic control
Bromelain and proteolytic enzymes: Postoperative edema vs bleeding concerns
Collagen peptides: Friend to skin, foe to the bleb?
Curcumin after trabeculectomy: Can it modulate scarring without increasing bleeding?
Resveratrol and fibrosis pathways in the filtering bleb
A timing roadmap: Supplements that may be safe two weeks after trabeculectomy
Omega-3 fatty acids after trabeculectomy: Anti-inflammatory ally or bleeding risk?
Zinc and copper balance: Wound healing without tipping into fibrosis
N-acetylcysteine (NAC): Antioxidant replenishment and antifibrotic potential
Aqueous Humor and Tear Biomarkers: July 2026 Omics Updates
Laser Therapies Beyond SLT: July 2026 Protocol Innovations
Corneal Biomechanics as a Risk Modifier: Last-Month Evidence
Diurnal and Nocturnal Behavior of Episcleral Venous Pressure
The Optic Nerve Head Perfusion Equation: Venous Pressure, IOP, and Susceptibility to Damage
The IOP Floor: How Episcleral Venous Pressure Limits Trabecular and Canal-Based Glaucoma Procedures
Carotid-Cavernous Fistula and Glaucoma: Venous Hypertension at the Eye
Glutathione-centered strategies: NAC vs GlyNAC vs dietary sulfur donors
Week 2 After Trabeculectomy: Transitioning to Light Chores and Remote Work
Days 5–7 After Trabeculectomy: Completing Week One With Safer Routines and Visual Comfort
Days 3–4 After Trabeculectomy: Calming Inflammation While Staying Mobile
How Does the PreserFlo MicroShunt Stack Up Against Trabeculectomy and Other Drainage Devices?
Lowering Eye Pressure: The Lumigan vs Roclanda Showdown
Glaucoma Drainage Implants in Midlife: Decoding the Long-Term Success Rates
The Hidden Eye Risk in Athletes: Understanding Pigment Dispersion Syndrome and Pigmentary Glaucoma
Patient‑Reported Outcomes and Quality of Life After Glaucoma Procedures
The Glaucoma Shunt Journey: What to Expect Before, During, and After Surgery
Targeting Very Low IOPs: Achieving Single‑Digit Pressures Safely
SLT’s Evolving Role Relative to MIGS and Surgery
Trabeculectomy vs Tube Shunts in the Modern Era: Long-Term Safety and Durability
Do Orally Ingested Collagen Peptides Reach the Eye
Collagen Peptides and the Trabecular Meshwork: Mechanistic Links to Intraocular Pressure
Can Ferroptosis Supplements Protect Vision in Glaucoma? What the New Dnajb14 Discovery Really Means
Is Glaucoma an Energy Failure Disease? Mitochondria, Aging, and the Optic Nerve
The Future of Glaucoma Care May Be Personal: Matching Treatment to Each Patient’s Risk
Can the Optic Nerve Be Protected? The New Neuroprotection Era in Glaucoma Research
Sustained-release glaucoma implants
Disease-modifying glaucoma drugs
The Copper Peptide and the Optic Nerve: A Deep Look at GHK-Cu, Oxidative Stress, and Glaucoma
Brain Imaging Biomarkers and Plasticity in Glaucoma
Glaucoma and Glutamine: Is There a Real Link Through Glutamate, Retinal Metabolism, and Neurodegeneration?
Nocturnal hypotension, sleep apnea, and ocular perfusion: continuous monitoring studies
Economics of high-frequency home monitoring versus clinic-based perimetry
Color and contrast-specific perimetry to probe retinal ganglion cell subtype vulnerability
Inequities in access to visual field testing and their outcome consequences
Low-Carb Diets and Nocturnal Blood Pressure Dips: Ocular Perfusion Risks and Benefits
Macronutrient Patterns and Intraocular Pressure: A Systematic Evaluation
Personalized Nutrition in Glaucoma: Nutrigenomic Interactions with Macronutrient Metabolism
Medium-Chain Triglycerides vs Long-Chain Fats: Rapid Ketosis and Visual Function
Protein Intake, Homocysteine, and Pseudoexfoliation Glaucoma Risk
mTOR/Autophagy Modulation by Amino Acids in RGC Degeneration
NR vs NMN vs Nicotinamide for Glaucoma: Which NAD+ Booster Has the Strongest Evidence?
How Useful Is OCT at Each Stage of Glaucoma?
New Glaucoma Treatments in 2026: What Patients Should Know About Longer-Lasting Eye Pressure Control
Endothelin-1 Peptide and Glaucoma: Targeting a Problem Pathway
Substance P, Pain, and Neuroinflammation in Glaucoma
GLP-1 Peptides and Glaucoma Risk: What We Know and What to Watch
Nerve Growth Factor–Based Peptides and Optic Nerve Protection
Heat shock protein-derived peptides and autoimmunity in glaucoma
Endothelin pathway peptides and optic nerve head ischemia in glaucoma
MOTS-c and Glaucoma: A Mitochondrial Signal With Bigger Implications Than Eye Pressure?
Senolytics and the Glaucoma Niche: Clearing Old Cells for Longer-Life Signals
Ketogenic Signals and Beta-Hydroxybutyrate: IOP, Neuroprotection, and Longevity Intersections
The Glaucoma Energy Crisis: How Pyruvate Rescues Failing Eyes (And Why Your Fitness Level Matters)
Photobiomodulation (670 nm) for Aging Retina: Lifespan Signals from Flies to Mammals
What’s New in Glaucoma Research in April 2026? What Patients Should Know
A New Clue in Glaucoma: Leaky Blood Vessels May Damage Vision
April 2026 Glaucoma Trial Launches: A Global Landscape Review
April 2026 Glaucoma Trial Launches: A Global Landscape Review
Therapeutic Mechanisms Debuting in April 2026 Glaucoma Trials
Gene- and Cell-Based Therapies Entering Glaucoma Trials in April 2026
Home Tonometers and Contact Lens Sensors in April 2026 Protocols
Washout and Rescue Protocols in April 2026 IOP-Lowering Studies
Hyperbaric Oxygen Therapy and Glaucoma: Mechanistic Rationale and Biological Plausibility
Oxidative Stress, Hormesis, and the Hyperoxia Paradox in Glaucoma
Soccer and Glaucoma: Endurance Gains Amid Collision Risks
Hiking and Glaucoma: Terrain, Altitude, and Sun Exposure
Running and Jogging with Glaucoma: Balancing Cardiovascular Gains and IOP Fluctuations
Road Cycling and Glaucoma: Aerobic Advantage with Posture and Safety Considerations
Snorkeling and Glaucoma: Gentle Aquatic Activity with Mask and Sunlight Considerations
SCUBA Diving and Glaucoma: Pressure, Perfusion, and Post-Surgical Precautions
Lap Swimming and Glaucoma: Cardiorespiratory Benefits vs. Goggle and Head Position Issues
Basketball and Glaucoma: Dynamic Cardio with Contact and Glare Considerations
General Resistance Training and Glaucoma: Building Strength While Managing IOP Spikes
High-Intensity Interval Training (HIIT) and Glaucoma: Short Bouts, Big Questions
Can Eye Blood Vessel Changes Warn of Future Glaucoma Damage Before Vision Tests Turn Abnormal?
Does Angle-Closure Risk Build Up Earlier in Life Than People Think?
Can Exercise, Better Sleep, and Stress Reduction Help in Glaucoma? What a New March 2026 Study Suggests
If One Person in the Family Has Glaucoma, Should Everyone Else Get Checked?
A New Glaucoma Drug Study Is Starting: Could an Oral Cannabinoid Help Lower Eye Pressure?
What Was Actually New in Glaucoma This Month? A Plain-English Guide to the Most Important March 2026 Updates
Why Is It So Hard to Prove a Treatment Protects the Optic Nerve in Glaucoma?
A New Way to Read Eye Scans in Glaucoma: Can 3D Nerve Fiber Shape Improve Detection?
Could Better Scan Databases Help Catch Glaucoma Earlier? What a New March 2026 Study Found
Does Eye Pressure Damage Show Up Before Vision Gets Worse? A New March 2026 Glaucoma Study Explains the Time Lag
A Cataract Lens That Also Treats Glaucoma? What the New BIM-IOL Study Means for Patients
Why Vision Restoration Is So Much Harder in Glaucoma Than in Some Other Eye Diseases
Eyes Wide Open: How Karpathy's Autoresearch Framework Could Democratize Glaucoma Research — A Blueprint for Patient-Led, AI-Driven Discovery in Vision Restoration
Can a Light-Sensing Drug Help Restore Vision? Understanding the Newest KIO-301 Research
A Treatment That Helped Some Blind Patients See More Light and Shape: What MCO-010 Means for Vision Restoration
Helping New Cells Survive: How Tiny Drug Carriers May Support Future Vision Repair in Glaucoma
Could Cell Transplants One Day Restore Vision in Glaucoma? A New Study Looks at One Major Roadblock
A New Glaucoma Implant Study: Can It Protect Vision, and Can It Bring Lost Vision Back?
What Is a 24-2 Visual Field Test
How Fast Does Glaucoma Progress
Perioperative Pitfalls: Supplements That Raise Bleeding Risk in Glaucoma Surgery
Does Diabetes Cause Glaucoma
Can You Have Glaucoma in One Eye
Zinc, Copper, and Optic Neuropathy: When Supplements Mimic Glaucoma Progression
How Long Does a Glaucoma Test Take
Which Is Worse Cataracts or Glaucoma
Does Glaucoma Cause Headaches
How to Test for Glaucoma
Is Glaucoma a Disability
Is Glaucoma Genetic
What Is Narrow Angle Glaucoma
What Are the Symptoms of Glaucoma
How to Prevent Glaucoma
What Does Glaucoma Look Like
What Causes Glaucoma
Magnesium and Glaucoma: A Systematic Review of Human Evidence
Antioxidant Vitamins and Minerals: Do A, C, E, Zinc, and Selenium Matter in Glaucoma?
Sodium, Blood Pressure, and Ocular Perfusion: Dietary Salt in Glaucoma Care
Soy Foods, Phytoestrogens, and Glaucoma in Women
Lifestyle Levers to Extend Visual Healthspan
Blue Zones and Centenarians: Ocular Phenotypes of Exceptional Agers
Metformin, Rapamycin, and Geroscience Drugs: Ocular Outcomes
ER-100 Clinical Trial for Glaucoma: What We Know So Far and What to Expect
Glaucoma Eye Drops, Dry Eye, and Sleep Quality: Exploring Hidden Connections and What Patients Can Do
The Ocular Microbiome, Inflammaging, and Surface Health
Methods of Visual Field Testing in Glaucoma: How They Differ and What Each Reveals
The Limitations of Visual Field Testing in Glaucoma: Frequency, Subjectivity, and What Gets Missed
Home Tonometry and Remote Monitoring in Glaucoma – A Patient-Centered Investigation
Predicting Glaucoma Before It Starts: How Close Are We to Genetic Risk Scores That Actually Change Patient Outcomes?
Glaucoma Clinical Trials Launched in 2025: A Complete Overview
Patterns of Vision Loss in Glaucoma: Large Blind Spots Versus Scattered Missing Points
How Fast Is AI Actually Progressing, and What Does It Mean for Glaucoma Patients and Researchers?
AI in Glaucoma: What's Working Now, What's Coming Next, and Where the Real Opportunities Lie
Glaucoma Vision Restoration: What's New in January 2026
Hydrogen Water Research Compiled: Studies, Dosages, Applications, and Outcomes
Pyruvate Supplementation for Glaucoma: Comparing Forms, Efficacy, and Global Availability
Nitric Oxide Pathway Supplements (L-Arginine, L-Citrulline) and Aqueous Outflow
Pyrroloquinoline Quinone (PQQ) and Mitochondrial Biogenesis in RGCs
Myopia and Glaucoma: When Nearsightedness Raises the Stakes
HDL cholesterol and apolipoprotein A-I: protective or paradoxical in glaucoma?
Complement proteins C3 and C4: systemic innate immunity and glaucoma progression
Systemic immune-inflammation index (SII) and the speed of RNFL loss
Coagulation markers (fibrinogen and D-dimer) and optic nerve microthrombosis
Redox Balance and Glaucoma: Is More Antioxidants Always Better for Your Eyes?
Red cell distribution width as a microvascular stress marker in glaucoma
Beyond the Marketing: Which Hydrogen Water Bottles Have Verified Test Results?
Hydrogen Water Buying Guide for Glaucoma-Focused Consumers: Science-First Approach
High-Sensitivity CRP: Systemic Inflammation and Glaucoma Neurodegeneration
ApoB, ApoA1, and Non-HDL Cholesterol: Refining Atherogenic Risk in Glaucoma Patients
Platelet Metrics (Mean Platelet Volume) and Microvascular Risk in Glaucoma
Uric Acid: Antioxidant Versus Pro-oxidant in Glaucoma
IGF-1, mTOR Signaling, and Neurodegeneration Across Eye and Brain
Oxidative Stress Biomarkers, HRV, and Retinal Ganglion Cell Loss
Stacking Blood-Thinning Supplements: Cumulative Bleeding Risk in Glaucoma Patients
Selective Laser Trabeculoplasty in the Era of OTC Blood Thinners: Hyphema and IOP Spikes
SLT as First-Line Therapy: Who Benefits and When to Repeat
Neuroprotection Beyond Pressure: What’s Real, What’s Hype
Dry Eye Can Fake Progression: Fix the Surface, Fix the Tests
Contact Lenses With Glaucoma: Timing Drops, Preservatives, and Comfort
Adherence That Sticks: Storage, Travel, and Tech Tools for Glaucoma Drops
Vasospasm, Cold Hands, and Normal-Tension Glaucoma: The Raynaud’s Connection
Exercise Smart: Aerobic vs Weightlifting, Valsalva, and Yoga Inversions
Sleep Posture Hacks: Head Elevation and Side-Sleeping Effects on Eye Pressure
The Nighttime Blood Pressure Dip: A Hidden Driver in Normal-Tension Glaucoma
Measuring What Matters: Beyond Visual Fields to Functional Vision
Hydration Habits: Water-Drinking Spikes and How to Sip Safely
Mastering Eye Drop Technique: Nasolacrimal Occlusion to Boost Efficacy and Safety
Vitamins C and E in Glaucoma: Antioxidants Revisited
Mirtogenol (Pycnogenol + Bilberry) and Eye Pressure: A Critical Appraisal
Caffeine, Coffee, and Tea: How Do They Impact Eye Pressure?
Palmitoylethanolamide (PEA) as an Adjunct in Glaucoma
Can Restoring Ocular Perfusion Restore Vision? OCT-A and Vascular Therapies
Cortical Plasticity and Perceptual Learning: Can the Brain Compensate for Optic Nerve Damage?
ROCK Inhibitors Beyond IOP: Axonal Regrowth, Perfusion, and Neuroprotection
Brain Stimulation for Glaucoma: tDCS, TMS, and Visual Cortex Modulation
Circadian Biology, ipRGCs, and Neuroprotection in Glaucoma
The 2024–2025 Pipeline for IOP-Independent Neuroprotection in Glaucoma
Forecasting Glaucoma Vision Restoration: 5-, 10-, and 20-Year Outlook
Nicotinamide and Mitochondrial Rescue: Can Metabolic Therapy Restore Function?
Artificial Vision for End-Stage Glaucoma: Retinal vs. Cortical Prostheses
Stem Cell–Derived RGC Transplantation: From Petri Dish to Optic Tract
Electrical Stimulation for Glaucoma: Signal Boost or True Neurorestoration?
Gene Therapy for Optic Nerve Regeneration: Modulating PTEN/mTOR, KLFs, and Sox11
Quercetin and Fisetin as Candidate Senolytics in Optic Nerve Aging
Citrus Bioflavonoids (Hesperidin, Diosmin) for Ocular Hemodynamics
Molecular Hydrogen and Redox Signaling in Ocular Neuroprotection
Anthocyanins and Bilberry Extracts: Retinal Resilience and Aging Microvasculature
Taurine and Retinal Ganglion Cell Survival Across the Lifespan
Green Tea Catechins (EGCG) for Neurovascular Health in Glaucoma and Aging
Melatonin, Circadian Rhythms, and Nocturnal IOP Dynamics
The Gut–Eye Axis: Probiotics, Metabolites, and Intraocular Pressure
Magnesium for Vascular Dysregulation in Glaucoma and Aging Circulation
Resveratrol and Sirtuin Pathways: From Trabecular Meshwork to Longevity
Macular Carotenoids (Lutein, Zeaxanthin, Meso-zeaxanthin) Beyond the Macula
Saffron (Crocins) in Optic Neuroprotection: Translating Retinal Evidence to Glaucoma
Safety, Interactions, and Regulatory Oversight of Glaucoma Supplements
Spermidine and Autophagy: A Longevity Nutrient for the Aging Eye
Curcumin and Curcuminoids: Anti-inflammatory Strategies for Glaucoma Neuroprotection
Vitamin D Status, Intraocular Pressure, and Neuroinflammation
N-Acetylcysteine and Glutathione: Fortifying Antioxidant Defenses in the Aging Eye
From Bench to Bedside: Translating Longevity Pathways to Glaucoma Supplements
Omega-3 Fatty Acids, Inflammation Resolution, and Glaucoma Progression
Citicoline (CDP-Choline) for Visual Pathway Support and Cognitive Aging
Alpha-Lipoic Acid: Redox Modulation and Neurovascular Support in Glaucoma
Creatine and Energy Buffering in Retinal and Optic Nerve Tissues
Astaxanthin for Oxidative Stress and Ocular Blood Flow
Designing Multi-Ingredient Neuroprotective Formulations for Glaucoma
B Vitamins, Homocysteine, and Vascular Dysregulation in Glaucoma
Ginkgo biloba for Ocular Perfusion and Visual Field Preservation: Promise and Precautions
Coenzyme Q10 as a Mitochondrial Adjunct in Glaucoma and Lifespan Health
Tele-Glaucoma and Home Monitoring in Aging Populations
Nicotinamide and NAD+ Boosting for Glaucoma Neuroprotection and Healthy Aging